Recombinant interferon alpha-2a (Changchun ChangSheng Gene Pharmaceutical)

重组人干扰素α2a凝胶

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant interferon alpha-2a (Changchun ChangSheng Gene Pharmaceutical)
Drug Alias Name忆林Yilin
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHerpes SimplexCondylomata Acuminata
Global Approved IndicationsHerpes SimplexCondylomata Acuminata
Approved Indications in ChinaHerpes SimplexCondylomata Acuminata
Original Approved Country/TerritoryMainland China
Original Approved Date2004/09/14
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun Changsheng Gene Pharmaceutical Stock Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Changsheng Gene Pharmaceutical Stock Co Ltd
Inactive CompaniesN/A
Active IndicationsHerpes SimplexCondylomata Acuminata
Inactive IndicationsN/A

Other Information

ATC CodeL03AB04
Related LinksN/A